Purple Biotech (PPBT) vs SciSparc (SPRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SciSparc is the larger company by market cap ($2.6 million vs $2.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | PPBT | SPRC |
|---|---|---|
| Share price | $1.44 | $4.43 |
| Market cap | $2.34M | $2.57M |
| 1-day change | -1.37% | -4.53% |
| P/E ratio (TTM) | — | 0.02 |
| EPS (TTM) | $-47.64 | $248.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.10 | $43.65 |
| 52-week low | $1.16 | $2.98 |
| Distance from 52-week high | -89.79% | -89.85% |
| Average volume | 1.28M | 180.20K |
| Shares outstanding | 1.63M | 580.97K |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PPBT vs SPRC FAQ
Which is bigger, Purple Biotech or SciSparc?
SciSparc (SPRC) is larger, with a market capitalization of $2.57M compared with $2.34M for Purple Biotech (PPBT).
Are Purple Biotech and SciSparc in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.